Logo image
Elevated Myocardial Extracellular Volume Fraction in Duchenne Muscular Dystrophy
Journal article   Peer reviewed

Elevated Myocardial Extracellular Volume Fraction in Duchenne Muscular Dystrophy

James J Starc, Ryan A Moore, Mantosh S Rattan, Chet R Villa, Zhiqian Gao, Wojciech Mazur, John L Jefferies and Michael D Taylor
Pediatric cardiology, v 38(7), pp 1485-1492
01 Oct 2017
PMID: 28762167

Abstract

Adolescent Cardiomyopathies - diagnostic imaging Cardiomyopathies - etiology Cardiomyopathies - pathology Child Contrast Media Extracellular Space - diagnostic imaging Humans Magnetic Resonance Imaging, Cine - methods Male Muscular Dystrophy, Duchenne - complications Muscular Dystrophy, Duchenne - diagnostic imaging Myocardium - pathology Observer Variation Radiographic Image Enhancement - methods Retrospective Studies Ventricular Function, Left - physiology Young Adult
Duchenne muscular dystrophy (DMD) is a genetic, X-linked recessive disease with an associated cardiomyopathy characterized by myocardial fibrosis leading to heart failure, arrhythmias, and death. Earlier detection and treatment of cardiac involvement in DMD hold potential to improve outcomes. Cardiovascular magnetic resonance (CMR) extracellular volume (ECV) quantification using T1 mapping is a histologically validated, non-invasive marker of diffuse fibrosis. This study aims to determine the ECV in a pediatric DMD population, and correlate it with metrics of left ventricular function. A retrospective review of pediatric DMD subjects who underwent CMR at a single institution. A total of 47 DMD patients (mean age 14 ± 2 years) were included for analysis. Global myocardial ECV was significantly higher in the DMD group (29 ± 6%) compared with published normal values (24 ± 2%, p = 0.0001). Higher ECV values correlate with indices of left ventricular function, including decreased left ventricular ejection fraction (r = -0.46, p = 0.001) and indexed left ventricular end diastolic volume (r = 0.41, p = 0.004). ECV was not significantly higher in DMD patients with late gadolinium enhancement (LGE) (30 ± 7%) compared to DMD patients without LGE (27 ± 5%, p = 0.0717). CMR T1 mapping is a feasible method for quantification of ECV in patients with DMD. Global myocardial ECV is significantly higher in the DMD population compared to healthy controls and correlates with other metrics of myocardial function. Global myocardial ECV may serve as an important tool to determine cardiac involvement in DMD population and help guide medical management.

Metrics

12 Record Views
14 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Cardiac & Cardiovascular Systems
Pediatrics
Logo image